{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP01689",
    "Peptide Name": "LFT33 (Synthetic AMPs20, hybrid peptide)",
    "Source": "designed, hybrid peptide, man-made sequences",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "FKCRRWQWRWKKLGAKPVPIIYCNRRTGKCQRM",
    "Sequence Length": 33,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Antifungal"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 11,
    "Boman Index": 3,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "39%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar (57.58%) toLactoferricin BK: 15%, R: 18%. residues 1-15 LfcinB M10Y + residues 4-21 of thanatin.Activity: active against S. aureus ATCC25923 (IC50 16 ug/ml), P. aeruginosa ATCC27853 (IC50 32 ug/ml), E. coli O78 (IC50 32 ug/ml), S. pullorum CCVC533 (IC50 32 ug/ml), E. aerogenes HC2124 (IC50 16 ug/ml), K. pneumoniae HC2187 (IC50 32 ug/ml), and C. albicans HC3150 (IC50 64 ug/ml).Toxicity: human RBC: not hemo.lytic at 256 ug/ml.Recombinant production:bacteria:Escherichia coli: successfully expressed and purified, released by enterokinase, yield: 0.5 mg/liter.Entry history:The original entry has been replaced due to the same sequence as AP0286. Replaced 5/2024.",
    "Author": "Feng X, Liu C, Guo J, Song X, Li J, Xu W, Li Z.2012",
    "Reference": "Appl Microbiol Biotechnol. 2012 Sep;95(5):1191-8. doi: 10.1007/s00253-011-3816-z.Pub-Med.",
    "Title": "ecombinant expression, purification, and antimicrobial activity of a novel hybrid antimicrobial peptide LFT33."
  },
  "3D Structure": []
}